Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

280 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Acetyl-L-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: an analysis of two randomized placebo-controlled trials.
Sima AA, Calvani M, Mehra M, Amato A; Acetyl-L-Carnitine Study Group. Sima AA, et al. Diabetes Care. 2005 Jan;28(1):89-94. doi: 10.2337/diacare.28.1.89. Diabetes Care. 2005. PMID: 15616239 Clinical Trial.
Acetyl-L-carnitine in the management of pain during methadone withdrawal syndrome.
Janiri L, Martinotti G, Tonioni F, Ghelardini C, Nicolai R, Galeotti N, Mosconi L, Calvani M, Bartolini A, Iannoni E. Janiri L, et al. Clin Neuropharmacol. 2009 Jan-Feb;32(1):35-40. doi: 10.1097/WNF.0B013E31815DD465. Clin Neuropharmacol. 2009. PMID: 18978503 Clinical Trial.
Acetyl-L-carnitine: from a biological curiosity to a drug for the peripheral nervous system and beyond.
Onofrj M, Ciccocioppo F, Varanese S, di Muzio A, Calvani M, Chiechio S, Osio M, Thomas A. Onofrj M, et al. Expert Rev Neurother. 2013 Aug;13(8):925-36. doi: 10.1586/14737175.2013.814930. Expert Rev Neurother. 2013. PMID: 23965166 Review.
Acetyl-L-carnitine: a drug able to slow the progress of Alzheimer's disease?
Carta A, Calvani M. Carta A, et al. Ann N Y Acad Sci. 1991;640:228-32. doi: 10.1111/j.1749-6632.1991.tb00223.x. Ann N Y Acad Sci. 1991. PMID: 1776743 Clinical Trial.
Idiopathic facial paralysis: new therapeutic prospects with acetyl-L-carnitine.
Mezzina C, De Grandis D, Calvani M, Marchionni A, Pomes A. Mezzina C, et al. Int J Clin Pharmacol Res. 1992;12(5-6):299-304. Int J Clin Pharmacol Res. 1992. PMID: 1301409 Clinical Trial.
Protective effect of acetyl-L-carnitine against oxidative stress induced by antiretroviral drugs.
Ferraresi R, Troiano L, Roat E, Nemes E, Lugli E, Nasi M, Pinti M, Calvani M, Iannuccelli M, Cossarizza A. Ferraresi R, et al. FEBS Lett. 2006 Dec 11;580(28-29):6612-6. doi: 10.1016/j.febslet.2006.11.016. Epub 2006 Nov 14. FEBS Lett. 2006. PMID: 17118360
Bloodletting ameliorates insulin sensitivity and secretion in parallel to reducing liver iron in carriers of HFE gene mutations.
Equitani F, Fernandez-Real JM, Menichella G, Koch M, Calvani M, Nobili V, Mingrone G, Manco M. Equitani F, et al. Diabetes Care. 2008 Jan;31(1):3-8. doi: 10.2337/dc07-0939. Epub 2007 Oct 24. Diabetes Care. 2008. PMID: 17959863
Baseline LIC correlated negatively with insulin secretion (NGT r(0) = -0.676, P M value) (NGT r(0) = -0.597, P = 0.009; diabetes r(0) = -0.535, P = 0.03) and positively with NAS (diabetes r(0) = 0.6 …
Baseline LIC correlated negatively with insulin secretion (NGT r(0) = -0.676, P
Role of acetyl-L-carnitine in the treatment of cognitive deficit in chronic alcoholism.
Tempesta E, Troncon R, Janiri L, Colusso L, Riscica P, Saraceni G, Gesmundo E, Calvani M, Benedetti N, Pola P. Tempesta E, et al. Int J Clin Pharmacol Res. 1990;10(1-2):101-7. Int J Clin Pharmacol Res. 1990. PMID: 2201652 Clinical Trial.
A double-blind, parallel, multicenter comparison of L-acetylcarnitine with placebo on the attention deficit hyperactivity disorder in fragile X syndrome boys.
Torrioli MG, Vernacotola S, Peruzzi L, Tabolacci E, Mila M, Militerni R, Musumeci S, Ramos FJ, Frontera M, Sorge G, Marzullo E, Romeo G, Vallee L, Veneselli E, Cocchi E, Garbarino E, Moscato U, Chiurazzi P, D'Iddio S, Calvani M, Neri G. Torrioli MG, et al. Am J Med Genet A. 2008 Apr 1;146A(7):803-12. doi: 10.1002/ajmg.a.32268. Am J Med Genet A. 2008. PMID: 18286595 Clinical Trial.
The carnitine system and body composition.
Reda E, D'Iddio S, Nicolai R, Benatti P, Calvani M. Reda E, et al. Acta Diabetol. 2003 Oct;40 Suppl 1:S106-13. doi: 10.1007/s00592-003-0040-z. Acta Diabetol. 2003. PMID: 14618447 Review.
280 results
Jump to page